HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversible posterior leukoencephalopathy syndrome induced by sunitinib.

AuthorsGerman Martín, Lorena Bellido, Juan Jesus Cruz
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 25 Issue 23 Pg. 3559 (Aug 10 2007) ISSN: 1527-7755 [Electronic] United States
PMID17687168 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib
Topics
  • Aged
  • Antineoplastic Agents (adverse effects)
  • Bone Neoplasms (secondary)
  • Brain (pathology)
  • Brain Diseases (chemically induced, diagnosis)
  • Carcinoma, Renal Cell (drug therapy)
  • Female
  • Humans
  • Indoles (adverse effects)
  • Kidney Neoplasms (drug therapy)
  • Magnetic Resonance Imaging
  • Neoplasm Metastasis
  • Pyrroles (adverse effects)
  • Seizures (chemically induced)
  • Sunitinib
  • Syndrome
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: